Who is this course for?
Medical, Mental Health and Allied Health Professionals in Australia
The course is based on the CIIS program, adapted for the Australian context, and with input from MAPS, USONA, and others. It teaches therapists the research, therapy setting, risks, and therapeutic models for working with psychedelics.
Mind Medicine Australia
English
The Certificate in Psychedelic-Assisted Therapies (CPAT) by Mind Medicine Australia (MMA) is designed to meet the growing demand for trained therapists to provide regulatory-approved and research-backed psychedelic-assisted therapies for mental ill-health treatment in Australia. The course also prepares clinicians to work in research trials as they expand within the country.
Following world best practices, the CPAT is developed based on protocols from MAPS and the REBUS model by Imperial College London. The course aims to equip therapists with state change and stage change theory and technique, provide a theory of mind perspective, train therapists for future demands, help with the mental health crisis, contribute to changing attitudes and supporting legal changes, establish standards for safe and ethical practice, and bring together medical approaches with good psychotherapy standards and transpersonal aspects.
The CPAT program was developed through collaboration with experienced psychotherapists and incorporated live lectures, webcasts, self-study, and experiential workshops led by a skilled teaching team. The course respects the local context within Australia, making it the first program of its kind in the Southern Hemisphere.
Medical, Mental Health and Allied Health Professionals in Australia
The course has 4 assessment requirements:
Australian registered charity founded in 2019 that successfully campaigned for the Therapeutic Goods Administration (TGA) to reschedule psilocybin and MDMA in 2023 — making Australia the first country to formally approve these substances for clinical use. MMA trains clinicians through its Certificate in Psychedelic-Assisted Therapies (CPAT) program, funds clinical trials, and has supplied medicines and training to 100+ patients under the TGA Authorised Prescriber scheme.
Medical, Mental Health and Allied Health Professionals in Australia
The course has 4 assessment requirements:
Format: Hybrid.
The listed price is $9,950. Confirm the latest tuition, fees, and payment options with [object Object].
The listing includes a certificate signal. Accreditation note: CME. Confirm credential eligibility directly with the provider before enrolling.
The listed next cohort date is 2026-06-01.
The current listing status is Discontinued. Use the provider website for the latest enrollment status.
By Alma Institute
Shares course skills and categories
Integration courses focused on making sense of psychedelic experiences and turning insights into practical next steps. The directory page groups courses that cover integration as a clinical, facilitation, or personal-development skill.
Next cohort: Jul 13, 2026
By Fluence
Shares course skills and categories
This page lists courses on ketamine use in therapy and ketamine-assisted treatment for mental health conditions. The listings include training on safety, screening, administration, integration, and related clinical topics, with some courses noting continuing education eligibility and in-person or experiential component
Next cohort: Jul 13, 2026
By Third Wave
Shares course skills and categories
The Third Wave’s Coaching Certification Program is a six-month-long program that teaches one to become a psychedelic coach.
Next cohort: Aug 3, 2026
Source lists: Estimated 50 hours
Delivery: Online + Costa Rica
Includes medicine self-experience